Chemoinformaics analysis of 8-Hydroxycalamenene
Molecular Weight | 218.34 | nRot | 1 |
Heavy Atom Molecular Weight | 196.164 | nRig | 11 |
Exact Molecular Weight | 218.167 | nRing | 2 |
Solubility: LogS | -5.081 | nHRing | 0 |
Solubility: LogP | 4.805 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
nHA | 1 | APOL | 40.5214 |
nHD | 1 | BPOL | 22.0706 |
QED | 0.743 |
Synth | 3.326 |
Natural Product Likeliness | 1.775 |
NR-PPAR-gamma | 0.012 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.051 |
Pgp-sub | 0.005 |
HIA | 0.006 |
CACO-2 | -4.573 |
MDCK | 0.0000174 |
BBB | 0.714 |
PPB | 0.978813 |
VDSS | 3.841 |
FU | 0.0241184 |
CYP1A2-inh | 0.556 |
CYP1A2-sub | 0.942 |
CYP2c19-inh | 0.719 |
CYP2c19-sub | 0.923 |
CYP2c9-inh | 0.528 |
CYP2c9-sub | 0.948 |
CYP2d6-inh | 0.202 |
CYP2d6-sub | 0.856 |
CYP3a4-inh | 0.386 |
CYP3a4-sub | 0.729 |
CL | 7.854 |
T12 | 0.192 |
hERG | 0.035 |
Ames | 0.091 |
ROA | 0.332 |
SkinSen | 0.39 |
Carcinogencity | 0.054 |
EI | 0.708 |
Respiratory | 0.903 |
NR-Aromatase | 0.023 |
Antiviral | Yes |
Prediction | 0.776162 |